Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)
Clinical trial NCT06513312 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06513312
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-07
- Primary completion
- 2026-05-28
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.